Merck & Co., Inc. (MRK) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $115.48 +1.41%
Revenue Growth %: +3.5%
Financial Fact:
Taxes on Income: 2.75B
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +3.5%
Financial Fact:
Taxes on Income: 2.75B
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q3 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $12 million versus the consensus estimate of $11.61 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck's tulisokibart meets Phase 3 endpoints in ulcerative colitis trial
- Smith & Wesson Brands (SWBI) Tops Q4 EPS by 15c
- FDA approves Merck's Capvaxive for children at higher pneumonia risk
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
